Home
>
National Drug Code (NDC)
>
CLINIMIX E
CLINIMIX E - 0338-1142-03 - (Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Ma)
Drug Information of CLINIMIX E
| Product NDC: | 0338-1142 |
| Proprietary Name: | CLINIMIX E |
| Non Proprietary Name: | Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Ma |
| Active Ingredient(s): | 570; 316; 33; 5; 283; 132; 165; 201; 159; 51; 110; 154; 261; 187; 138; 217; 112; 116; 50; 11; 160 mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL & nbsp; Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Ma |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CLINIMIX E
| Product NDC: | 0338-1142 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020678 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110205 |
Package Information of CLINIMIX E
| Package NDC: | 0338-1142-03 |
| Package Description: | 1000 mL in 1 BAG (0338-1142-03) |
NDC Information of CLINIMIX E
| NDC Code | 0338-1142-03 |
| Proprietary Name | CLINIMIX E |
| Package Description | 1000 mL in 1 BAG (0338-1142-03) |
| Product NDC | 0338-1142 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Ma |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110205 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE |
| Strength Number | 570; 316; 33; 5; 283; 132; 165; 201; 159; 51; 110; 154; 261; 187; 138; 217; 112; 116; 50; 11; 160 |
| Strength Unit | mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Pharmaceutical Classes | Amino Acid [EPC],Amino Acids [Chemical/Ingredient],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] |
